high-risk human papillomavirus testing detects clinically relevant high-grade cervical intraepithelial neoplasia earlier than cytology in cervical screening permitting extension of the screening interval: five-year follow-up results of the randomised controlled POBASCAM trial

N.W. Bulkmans; J. Berkhof; L. Rozendaal; F.J. van Kemenade; A.J.P. Boeke; S. Bulk; F.J. Voorhorst; RHM Verheijen; K.  van Groningen; M.E. Boon; W. Ruitinga; M. van Ballegooijen; P.J.F. Snijders; C.J.L.M. Meijer

high-risk human papillomavirus testing detects clinically relevant high-grade cervical intraepithelial neoplasia earlier than cytology in cervical screening permitting extension of the screening interval: five-year follow-up results of the randomised controlled POBASCAM trial

N.W. Bulkmans, J. Berkhof, L. Rozendaal, F.J. van Kemenade, A.J.P. Boeke, S. Bulk, F.J. Voorhorst, RHM Verheijen, K. van Groningen, M.E. Boon, W. Ruitinga, M. van Ballegooijen, P.J.F. Snijders, C.J.L.M. Meijer

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	1764-1772
Journal	The Lancet
Volume	370
Publication status	Published - 2007

Cite this

Bulkmans, N. W., Berkhof, J., Rozendaal, L., van Kemenade, F. J., Boeke, A. J. P., Bulk, S., Voorhorst, F. J., Verheijen, RHM., van Groningen, K., Boon, M. E., Ruitinga, W., van Ballegooijen, M., Snijders, P. J. F., & Meijer, C. J. L. M. (2007). high-risk human papillomavirus testing detects clinically relevant high-grade cervical intraepithelial neoplasia earlier than cytology in cervical screening permitting extension of the screening interval: five-year follow-up results of the randomised controlled POBASCAM trial. The Lancet, 370, 1764-1772.

Bulkmans, N.W. ; Berkhof, J. ; Rozendaal, L. et al. / high-risk human papillomavirus testing detects clinically relevant high-grade cervical intraepithelial neoplasia earlier than cytology in cervical screening permitting extension of the screening interval: five-year follow-up results of the randomised controlled POBASCAM trial. In: The Lancet. 2007 ; Vol. 370. pp. 1764-1772.

@article{d7a98b02df2b4236be304bc6d27e3ed0,

title = "high-risk human papillomavirus testing detects clinically relevant high-grade cervical intraepithelial neoplasia earlier than cytology in cervical screening permitting extension of the screening interval: five-year follow-up results of the randomised controlled POBASCAM trial",

author = "N.W. Bulkmans and J. Berkhof and L. Rozendaal and {van Kemenade}, F.J. and A.J.P. Boeke and S. Bulk and F.J. Voorhorst and RHM Verheijen and {van Groningen}, K. and M.E. Boon and W. Ruitinga and {van Ballegooijen}, M. and P.J.F. Snijders and C.J.L.M. Meijer",

year = "2007",

language = "English",

volume = "370",

pages = "1764--1772",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

}

Bulkmans, NW, Berkhof, J, Rozendaal, L, van Kemenade, FJ, Boeke, AJP, Bulk, S, Voorhorst, FJ, Verheijen, RHM, van Groningen, K, Boon, ME, Ruitinga, W, van Ballegooijen, M, Snijders, PJF & Meijer, CJLM 2007, 'high-risk human papillomavirus testing detects clinically relevant high-grade cervical intraepithelial neoplasia earlier than cytology in cervical screening permitting extension of the screening interval: five-year follow-up results of the randomised controlled POBASCAM trial', The Lancet, vol. 370, pp. 1764-1772.

high-risk human papillomavirus testing detects clinically relevant high-grade cervical intraepithelial neoplasia earlier than cytology in cervical screening permitting extension of the screening interval: five-year follow-up results of the randomised controlled POBASCAM trial. / Bulkmans, N.W.; Berkhof, J.; Rozendaal, L. et al.
In: The Lancet, Vol. 370, 2007, p. 1764-1772.

Research output: Contribution to journal › Letter › Academic › peer-review

TY - JOUR

T1 - high-risk human papillomavirus testing detects clinically relevant high-grade cervical intraepithelial neoplasia earlier than cytology in cervical screening permitting extension of the screening interval: five-year follow-up results of the randomised controlled POBASCAM trial

AU - Bulkmans, N.W.

AU - Berkhof, J.

AU - Rozendaal, L.

AU - van Kemenade, F.J.

AU - Boeke, A.J.P.

AU - Bulk, S.

AU - Voorhorst, F.J.

AU - Verheijen, RHM

AU - van Groningen, K.

AU - Boon, M.E.

AU - Ruitinga, W.

AU - van Ballegooijen, M.

AU - Snijders, P.J.F.

AU - Meijer, C.J.L.M.

PY - 2007

Y1 - 2007

M3 - Letter

SN - 0140-6736

VL - 370

SP - 1764

EP - 1772

JO - The Lancet

JF - The Lancet

ER -

Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJP, Bulk S et al. high-risk human papillomavirus testing detects clinically relevant high-grade cervical intraepithelial neoplasia earlier than cytology in cervical screening permitting extension of the screening interval: five-year follow-up results of the randomised controlled POBASCAM trial. The Lancet. 2007;370:1764-1772.